Drug intelligence / Profile preview

tridihexethyl

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous
01

Overview

Tridihexethyl is a synthetic anticholinergic and antimuscarinic small molecule drug that was primarily used as its chloride salt. It acts as an antagonist at muscarinic acetylcholine receptors (M1, M2, and M3 subtypes), thereby inhibiting the action of acetylcholine on these receptors. This results in pronounced antispasmodic and antisecretory effects on the gastrointestinal tract by reducing vagally mediated reflexes and gastric acid secretion. Tridihexethyl was indicated as an adjunct in the treatment of peptic ulcer disease and has also been studied for acquired nystagmus. The drug is no longer available in the US market due to side effects and limited use[1][2][3][4][6].

Brand names
PathilonPropethonum
Other names
tridihexethyl chloridetridihexethyl (chloride)
02

Targets

M1 (Muscarinic acetylcholine receptor M1)CHRM3 (M3)CHRM2 (M2)

Beyond the preview

Go deeper on tridihexethyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tridihexethyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call